tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Schmitz, 45 are a BUY (83.33%), 9 are a HOLD (16.67%).
Analyst Michael Schmitz, carries an average stock price target met ratio of 69.74% that have a potential upside of 60.79% achieved within 572 days. Previously, Michael Schmitz worked at GUGGENHEIM, STIFEL, LADENBURG.
Michael Schmitz’s has documented 106 price targets and ratings displayed on 23 stocks. The coverage was on Energy, Healthcare, Financial Services sectors.
Most recent stock forecast was given on RVMD, Revolution Medicines at 19-Jan-2026.
Analyst best performing recommendations are on EQT (EQT).
The best stock recommendation documented was for EQT (EQT) at 2/28/2020. The price target of $8 was fulfilled within 14 days with a profit of $2.5 (45.45%) receiving and performance score of 32.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 31-Oct-2024
$14
$-60.27 (-81.15%)
$70
1 years 8 months 12 days ago
(31-Oct-2024)
10/11 (90.91%)
$-60.27 (-81.15%)
55
Buy Since 27-Jul-2021
$74.28
$0.01 (0.01%)
$75
3 years 8 months 19 days ago
(24-Oct-2022)
7/10 (70%)
$0.38 (0.51%)
92
Hold Since 12-Jan-2021
$74
$-0.27 (-0.36%)
$72
3 years 8 months 19 days ago
(24-Oct-2022)
9/9 (100%)
$0.1 (0.14%)
48
Hold Since 19-Oct-2022
$74
$-0.27 (-0.36%)
$67
3 years 8 months 24 days ago
(19-Oct-2022)
11/14 (78.57%)
$0.43 (0.58%)
25
Sell Since 18-Oct-2022
$74
$-0.27 (-0.36%)
$70
3 years 8 months 25 days ago
(18-Oct-2022)
9/11 (81.82%)
$0.32 (0.43%)
16
Which stock is Michael Schmitz is most bullish on?
What Year was the first public recommendation made by Michael Schmitz?
